Indranil Banerjee

ORCID: 0000-0002-9396-8306
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Radiopharmaceutical Chemistry and Applications
  • Medical Imaging Techniques and Applications
  • RNA Interference and Gene Delivery
  • Neuroendocrine Tumor Research Advances
  • Nanoparticle-Based Drug Delivery
  • Peptidase Inhibition and Analysis
  • MicroRNA in disease regulation
  • Nanoplatforms for cancer theranostics
  • Cancer Treatment and Pharmacology
  • Cancer Mechanisms and Therapy
  • Glioma Diagnosis and Treatment
  • Phagocytosis and Immune Regulation
  • Immunotherapy and Immune Responses
  • Cancer, Hypoxia, and Metabolism
  • Circular RNAs in diseases
  • Autophagy in Disease and Therapy
  • TGF-β signaling in diseases
  • Immune cells in cancer
  • Wnt/β-catenin signaling in development and cancer
  • Cancer Cells and Metastasis
  • Cancer therapeutics and mechanisms
  • Lung Cancer Research Studies
  • Liver Disease Diagnosis and Treatment
  • Advancements in Transdermal Drug Delivery
  • Protein Degradation and Inhibitors

Indian Institute of Technology Kharagpur
2018-2023

Techno India Group (India)
2022-2023

Virginia Commonwealth University
2021-2022

Indian Institute of Chemical Biology
2012-2020

Council of Scientific and Industrial Research
2012-2019

There is a pressing need for ubiquitously expressed antigen or receptor on the tumor surface successful mitigation of deleterious side effects chemotherapy. Phosphatidylserine (PS), normally constrained to intracellular surface, exposed external tumors and most tumorigenic cell lines. Here we report that novel PS-targeting liposome, phosphatidylcholine-stearylamine (PC-SA), induced apoptosis showed potent anticancer as single agent against majority cancer We experimentally proved this was...

10.1016/j.omtn.2017.10.019 article EN cc-by-nc-nd Molecular Therapy — Nucleic Acids 2017-12-05

Somatostatin receptor (SSTR) analog modified nanoparticles of paclitaxel (PSM) showed a superior anti-melanoma effect by inducing favorable systemic immune response.

10.1039/c8bm01403e article EN Biomaterials Science 2019-01-01

Significance No current therapies prevent recurrence in patients with glioblastoma multiforme (GBM). Extracellular matrix (ECM) remodeling and epithelial mesenchymal transition (EMT) are important processes regulating GBM progression acquisition of radiation temozolomide (radio/TMZ) resistance. Fli-1 choreographs ECM EMT via transcriptional regulation HSPB1. Lumefantrine, an antimalarial drug, inhibits the activities its downstream targets HSPB1, remodeling, EMT. Lumefantrine is selectively...

10.1073/pnas.1921531117 article EN Proceedings of the National Academy of Sciences 2020-05-14

Microbial lipopeptide “Iturin A” is a versatile bio-active molecule with potent antitumor action. Pre-clinical study of this showed very minimum toxicity in rodent model.

10.1039/c6ra13476a article EN RSC Advances 2016-01-01

Radiolabeled somatostatin analogs have become powerful tools in the diagnosis and staging of neuroendocrine tumors, which express receptors. The aim this study was to evaluate a new analog, 6-hydrazinopyridine-3-carboxylic acid-Ser3-octreotate (HYNIC-SATE) radiolabeled with 99mTc, using ethylenediamine-N,N'-diacetic acid tricine as coligands, be used radiopharmaceutical for vivo imaging receptor subtype 2 (SSTR2)-positive tumor. Synthesis peptide carried out on solid phase standard Fmoc...

10.1002/psc.2458 article EN Journal of Peptide Science 2012-10-26
Coming Soon ...